Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Trial of Adjuvant Radiotherapy Following Surgery and Chemotherapy in Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder

NCT02951325 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT02951325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02951325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Trial of Adjuvant Radiotherapy Following Surgery and Chemotherapy in Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder
Lead sponsor
Tata Memorial Centre
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 2, 2016
Completion date
April 13, 2030
Enrollment
153 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, urothelial carcinoma bladder